California Governor Gavin Newsom has blocked Louisiana’s attempt to extradite a California doctor accused of mailing abortion pills. This decision follows Louisiana Governor Jeff Landry’s request for extradition, as Louisiana has strict anti-abortion laws, contrasting with California’s protections for abortion providers. Newsom cited a 2022 executive order preventing state agencies from assisting in the prosecution of abortion providers from other states as the reason for his action. The doctor, Remy Coeytaux, faces criminal charges in Louisiana and potential jail time if convicted.
Read More
In a significant decision, the Wyoming Supreme Court ruled that two state laws banning abortion, including a unique ban on abortion pills, are unconstitutional. The court, comprised of justices appointed by Republican governors, sided with the state’s sole abortion clinic and others who challenged the bans enacted after the overturning of Roe v. Wade. The ruling affirmed the right of competent adults to make healthcare decisions under a state constitutional amendment. Governor Mark Gordon expressed disappointment and called for a constitutional amendment to ban abortion, which would be put to a vote this fall.
Read More
In Kentucky, a 35-year-old woman, Melinda Spencer, faces criminal charges related to the death of a “developed male infant.” Spencer allegedly admitted to clinic staff that she used medication ordered online to induce an abortion at her home, leading to the fetus’s death. Police reports indicate the fetus was buried in a shallow grave on her property. Spencer is charged with first-degree fetal homicide, abuse of a corpse, and tampering with physical evidence, which could result in severe penalties under Kentucky law.
Read More
The French National Assembly unanimously approved a bill to exonerate women penalized for having abortions before its legalization in 1975, a move supported by the government and the Senate. This legislation acknowledges the injustice of previous laws criminalizing abortion, recognizing the infringement on women’s rights and the widespread suffering caused. While not providing financial reparations, the law establishes a commission to preserve the memories of women who underwent secret abortions. This action aligns with France’s recent constitutional recognition of the right to terminate a pregnancy, a stance taken in response to global challenges to reproductive rights.
Read More
Former Vice President Mike Pence has publicly called for President Donald Trump to remove Robert F. Kennedy Jr. from his position as Health and Human Services Secretary, criticizing Kennedy’s actions regarding the abortion drug mifepristone. Pence’s advocacy group, Advancing American Freedom Foundation, issued a memo echoing this demand. This move sparked significant backlash online, with individuals like Michael Flynn and Jack Posobiec criticizing Pence’s statements and actions.
Read More
Meta has recently removed or restricted numerous accounts belonging to abortion access providers, queer groups, and reproductive health organizations worldwide. This wave of censorship, impacting over 50 organizations since October, includes bans on Facebook, Instagram, and WhatsApp, particularly affecting groups in Europe, the UK, Asia, Latin America, and the Middle East. While Meta denies an escalating trend, campaigners report a significant increase in account removals and restrictions compared to the previous year. Organizations affected by these actions, such as Women Help Women and Jacarandas, have expressed concerns about the lack of transparency, vague explanations for bans, and the potential life-threatening consequences of misinformation.
Read More
In a recent ruling, a federal judge in Hawaii found that the U.S. Food and Drug Administration unlawfully restricted access to mifepristone, a medication used for abortions and miscarriage management. The court determined the FDA violated the law by failing to provide a justified explanation for maintaining its restrictions, which include special certifications for prescribers and pharmacies. The ACLU, which brought the lawsuit, argued that the restrictions disproportionately impact patients with limited healthcare access, highlighting the medication’s safety and effectiveness. Although the FDA is instructed to reconsider its stance, the restrictions currently remain in place as the case navigates ongoing political pressures surrounding the medication.
Read More
As reported by the Associated Press, Maine Family Planning, a network of 18 clinics serving low-income residents, is closing its primary care operations due to the Trump administration’s cuts to abortion providers. The network, which offers a range of services beyond abortions, including cancer screenings and STD testing, stated the cuts forced them to make difficult decisions. The move to defund abortion providers is driving patients away from their doctors and has resulted in over 600 patients losing access to care. Maine Family Planning is fighting the funding cuts in federal court, with the Center for Reproductive Rights vowing to continue the legal battle.
Read More
The FDA has approved another generic version of the abortion pill mifepristone, a routine regulatory step. This approval, announced by Evita Solutions, immediately drew criticism from anti-abortion groups and Republican politicians. Despite the FDA’s assertion of limited discretion in generic drug approvals and statements on the safety and efficacy of the drug, some conservatives have expressed concern. The approval of this additional generic version is unlikely to affect access to the drug, which is typically taken in combination with misoprostol, though access to the medication is already restricted in many states.
Read More
The FDA recently approved a request to manufacture a generic version of mifepristone, a drug used in medication abortions, which has drawn sharp criticism from anti-abortion advocates. This approval allows Evita Solutions to produce its version of the drug, despite ongoing efforts to restrict access to mifepristone since the overturning of Roe v Wade. Critics, including some politicians and anti-abortion groups, have expressed outrage and questioned the FDA’s decision, citing safety concerns and recent studies. However, abortion rights supporters and medical professionals maintain that mifepristone is safe and effective, pointing to numerous studies supporting its use.
Read More
John Q. Hosedrinker